![Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine | FDA Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine | FDA](https://www.fda.gov/files/Booster%20Infographic_tw_12_28_21.png)
Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine | FDA
![OCHD ANNOUNCES MODERNA AND J&J BOOSTER AVAILABLE AT VACCINATION CLINICS FOR ELIGIBLE RESIDENTS – Ocean County Health Department OCHD ANNOUNCES MODERNA AND J&J BOOSTER AVAILABLE AT VACCINATION CLINICS FOR ELIGIBLE RESIDENTS – Ocean County Health Department](https://www.ochd.org/wp-content/uploads/2021/10/COVID-19-BOOSTER-SHOTS-2-1200x675.jpg)
OCHD ANNOUNCES MODERNA AND J&J BOOSTER AVAILABLE AT VACCINATION CLINICS FOR ELIGIBLE RESIDENTS – Ocean County Health Department
![Covid-19 Booster Vaccinations for Eligible Patients - Clinics October/November 2022 - Sirona Medical - Cabra, Dublin 7 - GP Practice Covid-19 Booster Vaccinations for Eligible Patients - Clinics October/November 2022 - Sirona Medical - Cabra, Dublin 7 - GP Practice](https://www.sironamedical.ie/wp-content/uploads/2022/09/HSE-Covid-Vaccination-journey-scaled.jpg)
Covid-19 Booster Vaccinations for Eligible Patients - Clinics October/November 2022 - Sirona Medical - Cabra, Dublin 7 - GP Practice
![COVID-19 vaccination – Social – Booster doses (Aboriginal and Torres Strait Islander people) | Australian Government Department of Health and Aged Care COVID-19 vaccination – Social – Booster doses (Aboriginal and Torres Strait Islander people) | Australian Government Department of Health and Aged Care](https://www.health.gov.au/sites/default/files/styles/h_content_max_width_no_upscale/public/2023-04/covid-19-vaccination-social-booster-doses-aboriginal-and-torres-strait-islander-people_0.png?itok=tIfsF7ik)
COVID-19 vaccination – Social – Booster doses (Aboriginal and Torres Strait Islander people) | Australian Government Department of Health and Aged Care
![COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022 | MMWR COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/72/wr/social-media/mm7206a3_COVIDIncidenceBivalentBooster_IMAGE_10Feb2023_1200x675.jpg?_=67112)
COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022 | MMWR
![CDC on X: "CDC strengthens recommendations and expands eligibility for #COVID19 vaccine booster shots. Read full statement: https://t.co/gGNakf1VB7 https://t.co/PBxSuZBFlx" / X CDC on X: "CDC strengthens recommendations and expands eligibility for #COVID19 vaccine booster shots. Read full statement: https://t.co/gGNakf1VB7 https://t.co/PBxSuZBFlx" / X](https://pbs.twimg.com/media/FTKGwc3XEAAHgD7.jpg)
CDC on X: "CDC strengthens recommendations and expands eligibility for #COVID19 vaccine booster shots. Read full statement: https://t.co/gGNakf1VB7 https://t.co/PBxSuZBFlx" / X
![Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA](https://www.fda.gov/files/Booster%20Infographic_D_Rev_010622_0.png)
Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA
![Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ... Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...](https://www.cdc.gov/mmwr/volumes/72/wr/social-media/mm7205e1_BivalentVECurrentSublineages_IMAGE_25Jan2023_1200x675-medium.jpg?_=95835)
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
![COVID-19 vaccine effectiveness in adolescents aged 12–17 years and interim public health considerations for administration of a booster dose | CDE Almería - Centro de Documentación Europea - Universidad de Almería COVID-19 vaccine effectiveness in adolescents aged 12–17 years and interim public health considerations for administration of a booster dose | CDE Almería - Centro de Documentación Europea - Universidad de Almería](https://www.cde.ual.es/wp-content/uploads/2022/02/Vaccine-ECDC.png)